Policies related to biopharmaceutical access and innovation.
Source-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- VENN STRATEGIES
- Client
- UCB, INC.
- Filing UUID
- 60e16199-badd-4414-af8d-eab42b46a656
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
International tax, corporate tax rate, and research and development tax issues.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.